azathioprine has been researched along with End Stage Liver Disease in 4 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
End Stage Liver Disease: Final stage of a liver disease when the liver failure is irreversible and LIVER TRANSPLANTATION is needed.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Secondary outcomes include safety and tolerability of MMF and azathioprine, time to remission, changes in Model For End-Stage Liver Disease (MELD)-score, adverse events, and aspects of quality of life." | 3.11 | Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial. ( Bakker, SF; Bartelink, M; Beuers, UHW; Biewenga, M; de Boer, YS; de Jonge, HJM; Drenth, JPH; Gevers, TJG; Gisbertz, IAM; Guichelaar, MMJ; Levens, AD; Pape, S; Pronk, MAMCB; Sebib Korkmaz, K; Sijtsma, MGM; Snijders, RJALM; Soufidi, K; Stoelinga, AEC; van den Berg, AP; van den Brand, FF; van der Meer, AJ; van Gerven, NMF; van Hoek, B; Vanwolleghem, T; Verdonk, RC; Verwer, BJ; Vrolijk, JM, 2022) |
| "An increased risk of colorectal cancer (CRC) is present also after LT in IBD patients with primary sclerosing cholangitis (PSC)." | 2.50 | Clinical management of inflammatory bowel disease in the organ recipient. ( Indriolo, A; Ravelli, P, 2014) |
| "Without prompt immunosuppressive treatment, autoimmune hepatitis is a devastating, albeit rare, liver disease." | 2.47 | Pharmacological management of autoimmune hepatitis. ( Mieli-Vergani, G; Vergani, D, 2011) |
| "16." | 1.46 | Autoimmune acute liver failure and seronegative autoimmune liver disease in children: Are they different from classical disease? ( Jain, V; Kathuria, R; Krishnani, N; Kumari, N; Poddar, U; Sarma, MS; Srivastava, A; Yachha, SK, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Snijders, RJALM | 2 |
| Stoelinga, AEC | 2 |
| Gevers, TJG | 2 |
| Pape, S | 2 |
| Biewenga, M | 2 |
| Verdonk, RC | 2 |
| de Jonge, HJM | 2 |
| Vrolijk, JM | 2 |
| Bakker, SF | 2 |
| Vanwolleghem, T | 2 |
| de Boer, YS | 2 |
| Pronk, MAMCB | 2 |
| Beuers, UHW | 2 |
| van der Meer, AJ | 2 |
| van Gerven, NMF | 2 |
| Sijtsma, MGM | 2 |
| Verwer, BJ | 2 |
| Gisbertz, IAM | 2 |
| Bartelink, M | 2 |
| van den Brand, FF | 2 |
| Sebib Korkmaz, K | 2 |
| van den Berg, AP | 2 |
| Guichelaar, MMJ | 2 |
| Soufidi, K | 2 |
| Levens, AD | 2 |
| van Hoek, B | 2 |
| Drenth, JPH | 2 |
| Jain, V | 1 |
| Srivastava, A | 1 |
| Yachha, SK | 1 |
| Kumari, N | 1 |
| Kathuria, R | 1 |
| Sarma, MS | 1 |
| Poddar, U | 1 |
| Krishnani, N | 1 |
| Indriolo, A | 1 |
| Ravelli, P | 1 |
| Vergani, D | 1 |
| Mieli-Vergani, G | 1 |
2 reviews available for azathioprine and End Stage Liver Disease
| Article | Year |
|---|---|
Clinical management of inflammatory bowel disease in the organ recipient.
Topics: Azathioprine; Cholangitis, Sclerosing; Colectomy; Colorectal Neoplasms; End Stage Liver Disease; Gra | 2014 |
Pharmacological management of autoimmune hepatitis.
Topics: Adult; Azathioprine; Child; Disease Progression; End Stage Liver Disease; Hepatitis, Autoimmune; Hum | 2011 |
1 trial available for azathioprine and End Stage Liver Disease
1 other study available for azathioprine and End Stage Liver Disease
| Article | Year |
|---|---|
Autoimmune acute liver failure and seronegative autoimmune liver disease in children: Are they different from classical disease?
Topics: Adolescent; Alanine Transaminase; Ascites; Aspartate Aminotransferases; Autoantibodies; Autoimmune D | 2017 |